Arkolith/Insider Trading/ONC/Form 4

Oyler John

Chief Executive Officer, DirectorBeOne Medicines Ltd. (ONC) · full profile →Form 4 · filed Jun 18, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$981K
Net Open-Market Flow
-$981K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 16, 2026Sell(S)2K$264.87$437K2K
Jun 16, 2026Sell(S)2K$265.99$455K333
Jun 16, 2026Sell(S)333$266.69$89K0

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001042047-26-000006) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML